Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jason Grebely

Showing results (301-310 of 368) with videos related to

Pageof 37
Sort By:
The International Journal on Drug Policy|March 24, 2024
96-week retention in treatment with extended-release subcutaneous buprenorphine depot injections among people with opioid dependence: Extended follow-up after a single-arm trialMichael Farrell, Jeyran Shahbazi, Mark Chambers, et al.
Drug and Alcohol Dependence|April 17, 2022
Willingness of people who inject drugs to participate in a randomised controlled trial involving financial incentives to initiate hepatitis C treatmentAlison D Marshall, Anna Conway, Evan B Cunningham, et al.
Viruses|November 27, 2024
A Pilot Randomised Controlled Trial Involving Financial Incentives to Facilitate Hepatitis C Treatment Uptake Among People Who Inject Drugs: ETHOS Engage StudyAlison D Marshall, Anna Conway, Evan B Cunningham, et al.
Journal of Addictive Diseases|August 3, 2022
Health-related quality of life in people receiving opioid agonist treatment and treatment for hepatitis C virus infectionOlav Dalgard, Alain H Litwin, Oren Shibolet, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|July 29, 2019
The Consensus Hepatitis C Cascade of Care: Standardized Reporting to Monitor Progress Toward EliminationKelly Safreed-Harmon, Sarah Blach, Soo Aleman, et al.
The Lancet. Gastroenterology & Hepatology|March 18, 2022
Interventions to enhance testing, linkage to care, and treatment initiation for hepatitis C virus infection: a systematic review and meta-analysisEvan B Cunningham, Alice Wheeler, Behzad Hajarizadeh, et al.
Journal of Hepatology|November 7, 2017
The contribution of alcohol use disorder to decompensated cirrhosis among people with hepatitis C: An international studyMaryam Alavi, Naveed Z Janjua, Mei Chong, et al.
Open Forum Infectious Diseases|March 15, 2016
Interferon Lambda 4 Genotype Is Associated With Jaundice and Elevated Aminotransferase Levels During Acute Hepatitis C Virus Infection: Findings From the InC3 CollaborativeKimberly Page, Ali Mirzazadeh, Thomas M Rice, et al.
The Lancet. Gastroenterology & Hepatology|April 27, 2017
Evaluation of the Xpert HCV Viral Load point-of-care assay from venepuncture-collected and finger-stick capillary whole-blood samples: a cohort studyJason Grebely, Francois M J Lamoury, Behzad Hajarizadeh, et al.
Drug and Alcohol Review|December 5, 2025
Factors Associated With Preferences for Opioid Agonist Therapies Among People Dependent on OpioidsM J Stowe, Anna Conway, Frederick L Altice, et al.
Pageof 37

Showing results (301-310 of 368) with videos related to

Sort By:
Pageof 37
The International Journal on Drug Policy|March 24, 2024
96-week retention in treatment with extended-release subcutaneous buprenorphine depot injections among people with opioid dependence: Extended follow-up after a single-arm trialMichael Farrell, Jeyran Shahbazi, Mark Chambers, et al.
Drug and Alcohol Dependence|April 17, 2022
Willingness of people who inject drugs to participate in a randomised controlled trial involving financial incentives to initiate hepatitis C treatmentAlison D Marshall, Anna Conway, Evan B Cunningham, et al.
Viruses|November 27, 2024
A Pilot Randomised Controlled Trial Involving Financial Incentives to Facilitate Hepatitis C Treatment Uptake Among People Who Inject Drugs: ETHOS Engage StudyAlison D Marshall, Anna Conway, Evan B Cunningham, et al.
Journal of Addictive Diseases|August 3, 2022
Health-related quality of life in people receiving opioid agonist treatment and treatment for hepatitis C virus infectionOlav Dalgard, Alain H Litwin, Oren Shibolet, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|July 29, 2019
The Consensus Hepatitis C Cascade of Care: Standardized Reporting to Monitor Progress Toward EliminationKelly Safreed-Harmon, Sarah Blach, Soo Aleman, et al.
The Lancet. Gastroenterology & Hepatology|March 18, 2022
Interventions to enhance testing, linkage to care, and treatment initiation for hepatitis C virus infection: a systematic review and meta-analysisEvan B Cunningham, Alice Wheeler, Behzad Hajarizadeh, et al.
Journal of Hepatology|November 7, 2017
The contribution of alcohol use disorder to decompensated cirrhosis among people with hepatitis C: An international studyMaryam Alavi, Naveed Z Janjua, Mei Chong, et al.
Open Forum Infectious Diseases|March 15, 2016
Interferon Lambda 4 Genotype Is Associated With Jaundice and Elevated Aminotransferase Levels During Acute Hepatitis C Virus Infection: Findings From the InC3 CollaborativeKimberly Page, Ali Mirzazadeh, Thomas M Rice, et al.
The Lancet. Gastroenterology & Hepatology|April 27, 2017
Evaluation of the Xpert HCV Viral Load point-of-care assay from venepuncture-collected and finger-stick capillary whole-blood samples: a cohort studyJason Grebely, Francois M J Lamoury, Behzad Hajarizadeh, et al.
Drug and Alcohol Review|December 5, 2025
Factors Associated With Preferences for Opioid Agonist Therapies Among People Dependent on OpioidsM J Stowe, Anna Conway, Frederick L Altice, et al.
Pageof 37